Clinical Oncology Next Generation Sequencing Market Size & Trends

Research Methodology – Clinical Oncology Next Generation Sequencing Market

At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Clinical Oncology Next Generation Sequencing Market comprises the following key stages:

Market Indicator & Macro-Factor Analysis

Our baseline thesis for the Clinical Oncology Next Generation Sequencing Market is developed by integrating key market indicators and macroeconomic variables. These include:

1 Factors considered while calculating market size and share

Prevalence and incidence rate of cancer globally.
Rate of adoption of Next Generation Sequencing (NGS) in diagnostic laboratories.
Government spending or investment on healthcare infrastructure.
Technological advancements and innovation in the field.
Size of the diagnostic and research laboratories adopting this technology.
The cost of NGS systems and services involved.
Competitor pricing strategies and market presence.
Regulatory policies and the reimbursement scenario.

2 Key Market Indicators

The number of new cancer cases diagnosed per year.
The number of laboratories investing in NGS.
Yearly healthcare expenditure by governments globally.
Research and development investment in Oncology NGS by healthcare companies.
Number of patents filed related to NGS technology.
Regulatory approvals of NGS systems and services.

3 Growth Trends

Increase in the number of partnerships and collaborations between diagnostic laboratories and NGS companies.
Increasing investments in research and development of Oncology NGS.
Increasing clinical trials ongoing related to NGS technologies.
Continuing technological advancements and innovations related to the field.
Increasing use of NGS for liquid biopsy in cancer detection and monitoring.
Emergence of cloud-based solutions for data management in NGS.
Growth of personalized medicine adding impetus to the oncology NGS market.

Secondary Research

Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Clinical Oncology Next Generation Sequencing Market. Key inputs include:

Company-Level Information

Annual reports, investor presentations, SEC filings
Company press releases and product launch announcements
Public executive interviews and earnings calls
Strategy briefings and M&A updates

Industry and Government Sources

Country-level industry associations and trade bodies
Government dossiers, policy frameworks, and official releases
Whitepapers, working papers, and public R&D initiatives
Relevant Associations for the Clinical Oncology Next Generation Sequencing Market

Market Intelligence Sources

Broker reports and financial analyst coverage
Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
Import/export trade data and tariff databases
Sector-specific journals, magazines, and news portals

Macro & Consumer Insights

Global macroeconomic indicators and their cascading effect on the industry
Demand–supply outlook and value chain analysis
Consumer behaviour, adoption rates, and commercialization trends

Primary Research

To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:

Expert Insights & KOL Engagements

Key Opinion Leader (KOL) Engagements
Structured interviews with executives, product managers, and domain experts
Paid and barter-based interviews across manufacturers, distributors, and end-users

Focused Discussions & Panels

Discussions with stakeholders to validate demand-supply gaps
Group discussions on emerging technologies, regulatory shifts, and adoption barriers

Data Validation & Business POV

Cross-verification of market sizing and forecasts with industry insiders
Capturing business perspectives on growth opportunities and restraints

Data Triangulation & Forecasting

The final step of our research involves data triangulation ensuring accuracy through cross-verification of:

Demand-side analysis (consumption patterns, adoption trends, customer spending)
Supply-side analysis (production, capacity, distribution, and market availability)
Macroeconomic & microeconomic impact factors

Forecasting is carried out using proprietary models that combine: